NCPA submitted comments in support of proposed rules in New York to address the egregious business practices of PBMs. NCPA offered constructive feedback to the Department of Financial Services to assist the Pharmacy Benefits Bureau in meeting their rulemaking objectives, which included creating a reimbursement floor applicable to the commercial market of NADAC plus a dispensing fee of $10.18, the state’s CMS-approved Medicaid dispensing fee, provisions to prevent patient steering, requirements for reimbursement parity with PBM-owned or affiliated pharmacies, audit protections, and network access parameters. NCPA supported a call to action initiated by the Pharmacy Society of the State of New York, resulting in more than 130 comment submissions from NCPA members. NCPA will keep members informed as the rulemaking process unfolds.
NCPA
